Precision will be well represented at ISPOR’s 20th Annual European Congress, to be held November 4-8 at the Scottish Events Campus, Glasgow, Scotland.
In addition to the numerous Precision-led short courses, issue panels, podium presentations, breakout sessions, workshops and poster presentations, please be sure to stop by the convention floor and visit us in Booth #702 to learn more from our experts, as well as take a demo of our new interactive online evidence synthesis platform, Precision ESP.
For a complete list of our scientific presentations, please see below:
(Precision participants in bold)
SHORT COURSE:
Sunday, November 5th, 1:00pm – 4:00pm
Network Meta-Analysis in Relative Effectiveness Research
Presenters: Jansen JP, Kanters S
BREAKOUT SESSIONS (2):
Monday, November 6th, 3:30pm – 4:30pm
Adherence Patterns Among Patients Using Oral Atypical Antipsychotics and Other Medications
Presenters: Shafrin J, Lakdawalla DN, MacEwan JP, Silverstein AP, Hatch A, Forma F
Tuesday, November 7th, 8:45am – 9:45am
Does Valuation of Innovation in Appraisal of New Technologies Provide Appropriate Incentives for Manufacturers and Access for Patients?
Presenters: Claxton K, Maclean R, Greuger J, Sculpher M
ISSUE PANEL:
Monday, November 6th, 5:00pm – 6:00pm
“Mind the Gap!”: The Gap Between Regulatory and Reimbursement Evidence Requirements for Medical Devices
Moderator: Zema C
WORKSHOPS (2):
Monday, November 6th, 6:15pm – 7:15pm
Rare Disease Research, HTA and Evidence for Reimbursement
Presenters: Blanchette CM, Nestler-Parr S, Redekop K
Wednesday, November 8th, 10:00am – 11:00am
Disconnected or Limited Evidence in Network Meta-Analysis: What Can Be Done?
Presenters: Jansen JP, Thom H, Leahy J
PODIUM PRESENTATION:
Monday, November 6th, 2:15pm – 3:15pm
Multivariate Network Meta-Analysis of Survival Function Parameters
Presenters: Cope S, Chan K, Jansen JP
POSTERS (10):
Monday, November 6th, Author Hour: 12:45pm – 1:45pm
An Empirical Analysis of the Role of Learning By Doing in Dynamic Cost-Effectiveness
Authors: Incerti D, Peneva D, Shrestha A, Ramaswamy K, Smith G, Stevens W
Monday, November 6th, Author Hour: 12:45pm – 1:45pm
Systematic Literature Review and Indirect Treatment Comparision of the Efficacy of Semaglutide Versus Empagliflozin As Add-On To Basal Insulin
Authors: Kanters S, Wilkinson L, Lopes S, Popoff E, Jansen JP, Ploug UJ
Monday, November 6th, Author Hour: 12:45pm – 1:45pm
Assessing the Healthcare Cost of Diabetic Non-Small Cell Lung Cancer Patients Compared to Non-Small Cell Lung Cancer Patients
Authors: Ruban C, Blanchette CM, Howden R, Kowalkowski M, Marino J, Saunders WB
Monday, November 6th, Author Hour: 6:30pm – 7:30pm
Burden of Renal Transplant Among A Cohort of US Medicare Beneficiaries with Autosomal Dominant Polycystic Kidney Disease
Authors: Blanchette CM, Noone JM, Zenarosa G, Howden R
Monday, November 6th, Author Hour: 6:30pm – 7:30pm
Investigation of Demographic Differences for Non-Small Cell Lung Cancer Patients With and Without Type 2 Diabetes
Authors: Ruban C, Blanchette CM, Howden R, Kowalkowski M, Marino J, Saunders WB
Monday, November 6th, Author Hour: 6:30pm – 7:30pm
Emergency Department Use Among Autosomal Dominant Polycystic Kidney Disease Patients in the US
Authors: Blanchette CM, Noone JM, Zenarosa G, Howden R
Monday, November 6th, Author Hour: 6:30pm – 7:30pm
Assessing the Utilization of Diabetic Non-Small Cell Lung Cancer Patients Compared to Non-Small Cell Lung Cancer Patients
Authors: Ruban C, Blanchette CM, Howden R, Kowalkowski M, Marino J, Saunders WB
Tuesday, November 7th, Author Hour: 12:30pm – 1:30pm
Cost-Consequence of Use Fluciclovine (F 18) for the Diagnosis and Staging of Recurring Prostate Cancer
Authors: Jensen IS, Wu C, Cyr PL, Gauden D
Wednesday, November 8th, Author Hour: 12:45pm – 1:45pm
Exploring Structural Uncertainty With An Open-Source Cost-Effectiveness Model for Rheumatoid Arthritis
Authors: Incerti D, Curtis JR, Lorenzi M, Jansen JP
Wednesday, November 8th, Author Hour: 12:45pm – 1:45pm
Parametric Modelling of Migrane Day Frequency in Migrane Prevention: A Case Study of Erenumab Clinical Trial Data
Authors: Porter JK, Di Tanna GL, Villa G, Brennan A, Palmer S, Lipton RB, Jansen JP, Shah N, Desai P, Sapra S
Wednesday, November 8th, Author Hour: 12:45pm – 1:45pm
Novel Biologics Versus Conventional Preventive Therapies in Migrane: A Framework for Economic Evaluation
Authors: Lipton RB, Brennan A, Palmer S, Jansen JP, Hatswell AJ, Porter JK, Di Tanna GL, Villa G, Shah N, Sapra S
